XBP1 promotes NRAS G12D pre-B acute lymphoblastic ...Wiley Online Library
onlinelibrary.wiley.com
von A Salimi · · Zitiert von: 1 — Mirle Schemionek-Reinders,. Mirle Schemionek-Reinders. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation ... von A Salimi · · Zitiert von: 1 — Mirle Schemionek-Reinders,. Mirle Schemionek-Reinders. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation ...
Novel imatinib-sensitive PDGFRA-activating point mutations in ...ashpublications.org
ashpublications.org
von C Elling · · Zitiert von: 87 — Mirle Schemionek,. Mirle Schemionek. 1Department of Medicine A, Hematology, Oncology, and Pneumology, University of Münster, Münster, Germany;. Search for ... von C Elling · · Zitiert von: 87 — Mirle Schemionek,. Mirle Schemionek. 1Department of Medicine A, Hematology, Oncology, and Pneumology, University of Münster, Münster, Germany;. Search for ...
Targeting of BCR-ABL1 and IRE1α induces synthetic lethality ...Oxford Academic
academic.oup.com
von M Vieri · · Zitiert von: 9 — Mirle Schemionek ,. Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation. , Aachen,. Germany. Search for other ... von M Vieri · · Zitiert von: 9 — Mirle Schemionek ,. Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation. , Aachen,. Germany. Search for other ...
Genomic instability may originate from imatinib-refractory ...ashpublications.org
ashpublications.org
von E Bolton-Gillespie · · Zitiert von: 134 — Mirle Schemionek,. Mirle Schemionek. 2Department of Medicine (Oncology, Hematology, and Stem Cell Transplantation), University Medical Center of Aachen ... von E Bolton-Gillespie · · Zitiert von: 134 — Mirle Schemionek,. Mirle Schemionek. 2Department of Medicine (Oncology, Hematology, and Stem Cell Transplantation), University Medical Center of Aachen ...
Combined BCR-ABL inhibition with lentiviral-delivered ...ScienceDirect.com
www.sciencedirect.com
von S Myssina · · Zitiert von: 4 — Baird d , Joanne C. Mountford a , Ashley Hamilton a , Mirle Schemionek e , Steffen Koschmieder e , Valerie G. Brunton b , Tessa L. Holyoake a. Show more. Add ... von S Myssina · · Zitiert von: 4 — Baird d , Joanne C. Mountford a , Ashley Hamilton a , Mirle Schemionek e , Steffen Koschmieder e , Valerie G. Brunton b , Tessa L. Holyoake a. Show more. Add ...
Infliximab therapy together with tyrosine kinase inhibition ...BMC Cancer
bmccancer.biomedcentral.com
von O Herrmann · · Zitiert von: 16 — Mirle Schemionek ORCID: orcid.org Show authors. BMC Cancer volume 19, Article number: 658 (2019) Cite this article von O Herrmann · · Zitiert von: 16 — Mirle Schemionek ORCID: orcid.org Show authors. BMC Cancer volume 19, Article number: 658 (2019) Cite this article
Growth Factor Deprivation Combined with Prolonged ...ScienceDirect.com
www.sciencedirect.com
von A Hamilton · · Zitiert von: 2 — ... Mirle Schemionek,5,* Steffen Koschmieder, MD,6 Valerie G Brunton,7,* Tessa L Holyoake1,* 1Section of Experimental Haematology, University of Glasgow ... von A Hamilton · · Zitiert von: 2 — ... Mirle Schemionek,5,* Steffen Koschmieder, MD,6 Valerie G Brunton,7,* Tessa L Holyoake1,* 1Section of Experimental Haematology, University of Glasgow ...
Targeting autophagy increases the efficacy of proteasome ...BMC Cancer
bmccancer.biomedcentral.com
von A Salimi · · Zitiert von: 8 — Writing – review & editing: Iris Appelmann, Azam Salimi, Mirle Schemionek, Deniz Gezer, Behzad Kharabi Masouleh. The authors read and ... von A Salimi · · Zitiert von: 8 — Writing – review & editing: Iris Appelmann, Azam Salimi, Mirle Schemionek, Deniz Gezer, Behzad Kharabi Masouleh. The authors read and ...
A phase I first-in-man study to investigate the ...Springer
link.springer.com
von J Metselaar · · Zitiert von: 2 — Amelie Boquoi, Roland Fenk, Mirle Schemionek, Susanne Isfort, Stefan Wilop & Martina Crysandt. Department of Hematology, Oncology and ... von J Metselaar · · Zitiert von: 2 — Amelie Boquoi, Roland Fenk, Mirle Schemionek, Susanne Isfort, Stefan Wilop & Martina Crysandt. Department of Hematology, Oncology and ...
Mast cell deficiency prevents BCR::ABL1 induced ...Nature
www.nature.com
von M Langhammer · · Zitiert von: 2 — Timo Jaquet, Henrike Jacobi, Steffen Koschmieder & Mirle Schemionek-Reinders. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf ... von M Langhammer · · Zitiert von: 2 — Timo Jaquet, Henrike Jacobi, Steffen Koschmieder & Mirle Schemionek-Reinders. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf ...
Alle Infos zum Namen "Mirle Schemionek"
Chronic myeloid leukemia stem cells are not dependent on ...Europe PMC
europepmc.org
von A Hamilton · · Zitiert von: 492 — ... Mirle Schemionek. 2Department of Medicine A, Hematology, Oncology and Pneumology, University of Münster, Münster, Germany;. Find articles by Mirle Schemionek ... von A Hamilton · · Zitiert von: 492 — ... Mirle Schemionek. 2Department of Medicine A, Hematology, Oncology and Pneumology, University of Münster, Münster, Germany;. Find articles by Mirle Schemionek ...
Chronic myeloid leukemia stem cells are not dependent on ...The University of Sunderland
sure.sunderland.ac.uk
von A Hamilton · · Zitiert von: 492 — Mirle Schemionek. Author: Bin Zhang. Author: Svetlana Mysina. Author: Elaine K Allan. Author: Franck E Nicolini. Author: Carsten Müller-Tidow. von A Hamilton · · Zitiert von: 492 — Mirle Schemionek. Author: Bin Zhang. Author: Svetlana Mysina. Author: Elaine K Allan. Author: Franck E Nicolini. Author: Carsten Müller-Tidow.
Identification of the Adapter Molecule MTSS1 as a Potential ...PLOS
journals.plos.org
von M Schemionek · · Zitiert von: 29 — Mirle Schemionek. Contributed equally to this work with: Mirle Schemionek, Behzad Kharabi Masouleh. Affiliation: Department of Hematology, Oncology ... von M Schemionek · · Zitiert von: 29 — Mirle Schemionek. Contributed equally to this work with: Mirle Schemionek, Behzad Kharabi Masouleh. Affiliation: Department of Hematology, Oncology ...
Intracellular Retention of ABL Kinase Inhibitors Determines ...PLOS
journals.plos.org
von DB Lipka · · Zitiert von: 27 — ... Mirle Schemionek, [...view 4 more...], Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder, Thomas Fischer [ view less ]. Daniel B ... von DB Lipka · · Zitiert von: 27 — ... Mirle Schemionek, [...view 4 more...], Junia V. Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder, Thomas Fischer [ view less ]. Daniel B ...
Novel imatinib-sensitive PDGFRA activating point mutations in ...ePrints Soton
eprints.soton.ac.uk
von C Elling · · Zitiert von: 87 — Mirle Schemionek. Author: Martin Stehling. Author: Hubert Serve. Author: Nicholas C.P. Cross · ORCID iD. Author: Andreas Hochhaus. Author: Wolf ... von C Elling · · Zitiert von: 87 — Mirle Schemionek. Author: Martin Stehling. Author: Hubert Serve. Author: Nicholas C.P. Cross · ORCID iD. Author: Andreas Hochhaus. Author: Wolf ...
PslD is a secreted protein required for biofilm formation by ...Europe PMC
europepmc.org
von A Campisano · · Zitiert von: 57 — ... Mirle Schemionek. Institute of Molecular Biosciences, Massey University, Private Bag , Palmerston North, New Zealand. Find articles by Mirle Schemionek ... von A Campisano · · Zitiert von: 57 — ... Mirle Schemionek. Institute of Molecular Biosciences, Massey University, Private Bag , Palmerston North, New Zealand. Find articles by Mirle Schemionek ...
The SCLtTAxBCR-ABL transgenic mouse model closely ...Oncotarget
www.oncotarget.com
von C Schubert · · Zitiert von: 8 — https://doi.org oncotarget Claudia Schubert, Nicolas Chatain, Till Braunschweig, Mirle Schemionek, Kristina Feldberg, ... von C Schubert · · Zitiert von: 8 — https://doi.org oncotarget Claudia Schubert, Nicolas Chatain, Till Braunschweig, Mirle Schemionek, Kristina Feldberg, ...
XBP1 promotes NRAS G12D pre-B acute lymphoblastic ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von A Salimi · · Zitiert von: 1 — Mirle Schemionek-Reinders , Michael Huber , Margherita Vieri , John B Patterson , Julia Alten , Tim H Brümmendorf , Behzad Kharabi Masouleh ... von A Salimi · · Zitiert von: 1 — Mirle Schemionek-Reinders , Michael Huber , Margherita Vieri , John B Patterson , Julia Alten , Tim H Brümmendorf , Behzad Kharabi Masouleh ...
PslD Is a Secreted Protein Required for Biofilm Formation by ...ASM Journals
journals.asm.org
von A Campisano · · Zitiert von: 57 — Andrea Campisano, Christine Schroeder, Mirle Schemionek, Joerg Overhage, and Bernd H. A. Rehm*. Institute of Molecular Biosciences, Massey ... von A Campisano · · Zitiert von: 57 — Andrea Campisano, Christine Schroeder, Mirle Schemionek, Joerg Overhage, and Bernd H. A. Rehm*. Institute of Molecular Biosciences, Massey ...
Targeting cytokine-induced leukemic stem cell persistence ...Haematologica
www.haematologica.org
von M Bütow · · Zitiert von: 4 — Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen ... von M Bütow · · Zitiert von: 4 — Mirle Schemionek. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen ...
sortiert nach Relevanz / Datum